The hidden genetics of epilepsy-a clinically important new paradigm

Grants

Funding Acknowledgements

S.F.B. declares that he has received honoraria and/or payments for development of educational presentations from Janssen-Cilag, Novartis Pharmaceuticals, Sanofi-Aventis, and UCB Pharma, and that he is an inventor on a patent for SCN1A testing owned by Bionomics and licensed to various diagnostic companies (WO/2006/133508); he has also applied for a patent for PCDH19 testing (WO/2009/086591). R.H.T. declares no competing interests.